Stockscreener 앱 받기
35.64
0.06%
0.02
시장 영업 전:
35.50
-0.14
-0.39%
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN
Aug Technicals: Does Collegium Pharmaceutical Inc offer margin of safetyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B - Moomoo
How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift - Yahoo Finance
Assessing Collegium Pharmaceutical (COLL) Valuation After Mixed Recent Share Price Performance - Sahm
Chipmakers Recap: What is the target price for Collegium Pharmaceutical Inc stockGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Sectors Review: Does Collegium Pharmaceutical Inc offer margin of safetyBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily
Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - TradingView — Track All Markets
Collegium to Participate in Upcoming Investor Conferences - Bitget
Collegium Pharmaceutical, Inc. (COLL) stock price, news, quote and history - Yahoo Finance UK
Collegium to webcast Needham fireside chat, post 90-day replay - Stock Titan
Collegium Pharmaceutical, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Filing Data (April 2, 2026) - Minichart
How Prospective US Tariffs on Branded Drug Imports Will Impact Collegium Pharmaceutical (COLL) Investors - Sahm
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo Finance UK
Inflation Data: What are analysts price targets for Collegium Pharmaceutical Inc2026 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Collegium (NASDAQ: COLL) posts strong 2025 growth and seeks backing on board, pay and auditor - Stock Titan
Collegium Pharmaceutical (NASDAQ: COLL) nominates Michael Donovan as director as John Fallon retires - Stock Titan
GE HealthCare and Collegium Pharmaceutical stocks trade down, what you need to know - MSN
Chipmakers Recap: Should I hold or sell Collegium Pharmaceutical Inc now2026 Highlights & Reliable Volume Spike Alerts - baoquankhu1.vn
COLL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Pullback - Sahm
Collegium (COLL) EVP has 8,840 shares withheld for RSU tax payment - Stock Titan
Collegium Pharmaceutical (COLL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical (COLL) surged following record quarterly results - MSN
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million - AOL.com
Collegium Pharma Executive David Dieter Sells Shares in March 2026News and Statistics - IndexBox
Collegium Pharmaceutical Acquires AZSTARYS for $650M - National Today
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers - Insider Monkey
Aug Volume: Can Collegium Pharmaceutical Inc be the next market leaderSell Signal & AI Enhanced Trading Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Acquires 139,689 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool
Wedge Capital Management L L P NC Acquires New Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Published on: 2026-03-30 05:44:15 - baoquankhu1.vn
Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case - ChartMill
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Time To Reassess Collegium Pharmaceutical (COLL) After The Recent Share Price Pullback? - simplywall.st
Collegium’s AZSTARYS Deal And Insider Sale Put Focus On Valuation - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in Collegium (COLL) - Stock Titan
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assenagon Asset Management S.A. - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025 - MSN
1.06%
1.05%
자본화:
|
볼륨(24시간):